about
Suspected Transfusion Related Acute Lung Injury Improving following Administration of Tranexamic Acid: A Case Report.Renal artery stenosis in patients with resistant hypertension.A suicide attempt by intoxication with Taxus baccata leaves and ultra-fast liquid chromatography-electrospray ionization-tandem mass spectrometry, analysis of patient serum and different plant samples: case reportCardiac arrest due to left circumflex coronary artery embolism as a complication of subtherapeutic oral anticoagulation in a patient with mitral and aortic mechanical valve prostheses.Cardiac arrest during percutaneous coronary intervention in a patient 'resistant' to clopidogrel - successful 50-minute mechanical chest compression.Renal Artery Denervation in Patient After Heart and Kidney Transplantation With Refractory Hypertension.Left main aneurysm and what's next?Characteristics of chaotic processes in electrocardiographically identified ventricular arrhythmia.DNA oxidative cleavage induced by the novel peptide derivatives of 3-(quinoxalin-6-yl)alanine in combination with Cu(II) or Fe(II) ions.MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study.A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade.Left ventricular function impairment in patients with normal-weight obesity: contribution of abdominal fat deposition, profibrotic state, reduced insulin sensitivity, and proinflammatory activation.Association of Abnormal Left Ventricular Functional Reserve With Outcome in Heart Failure With Preserved Ejection Fraction.Biventricular response of the heart to endurance exercise training in previously untrained subjects.Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction.Comparison of the renal hyperemic effects of papaverine and dopamine in patients with renal artery stenosis.Kidney microcirculation response to adenosine stimulation in renal artery stenosis.Expression of Proinflammatory Factors, Proangiogenic Factors and Endostatin in Patients with Heart Failure and Different Grades of Collateral Circulation Development.MMP-2 and TIMP-2 in Patients with Heart Failure and Chronic Kidney Disease.Integrated backscatter as a fibrosis marker in the metabolic syndrome: association with biochemical evidence of fibrosis and left ventricular dysfunctionReduced circulating apelin in essential hypertension and its association with cardiac dysfunctionContributions of Nondiastolic Factors to Exercise Intolerance in Heart Failure With Preserved Ejection FractionSuccessful renal artery denervation in a renal transplant recipient with refractory hypertensionImpact of the PPARGC1A Gly482Ser polymorphism on left ventricular structural and functional abnormalities in patients with hypertensionDeterminants of the beneficial effect of mineralocorticoid receptor antagonism on exercise capacity in heart failure with reduced ejection fractionThe evaluation of the aortic annulus displacement during cardiac cycle using magnetic resonance imagingDistribution of polymorphisms in the CYP2C19 and ABCB1 genes among patients with acute coronary syndrome in Lower Silesian population
P50
Q33786973-B4410854-A7C4-4754-8161-9E3D877DF61CQ34378370-C80E1F25-5332-4893-990C-51BA6596A8B8Q36117704-807708C0-4940-421E-8C2D-A0F5ACCDAC24Q37561812-5806A234-A86A-43FC-946B-CA5C3D65C5E9Q37589623-4ADD7088-D68F-4939-B230-689CB9D90D62Q38833934-A651EC4B-B9CA-44B4-A967-C946E37F3F53Q39142550-BB060F03-148E-48B0-93F8-A9F6CBE99B42Q39297002-F304B736-F796-4457-AC64-A5A3E8FC6AC4Q39500240-50ABA328-B055-4848-9871-AF5B772D39DEQ41099760-84E1B478-83F0-43BB-B0C7-FF2509881338Q44133735-4A00880A-BE6A-4B94-9F77-482A43166840Q45355746-F73CCEA4-40EC-4436-B8C7-07A302BCE073Q47322258-F47125CA-D326-4795-9A13-956FD78531ADQ47447152-A7BB4572-DE9A-4663-A950-3E5AAFD5F11EQ50609274-05B2DADF-AF9A-4405-A1D5-5DEB638CA827Q53563361-93FD98DD-9A07-4FB7-AFF3-069CAD1D1540Q53661452-7EA8D68A-32E0-49BC-8917-3BFF67D2A1B2Q53835618-BF23DEF2-8879-4DF4-A724-FE819AE48475Q55059529-EDB00D7D-B49A-4498-94B6-FFBFE2312BCEQ55233718-3EEA5E83-17CB-4D83-B9CA-5DCB1B24BE12Q83075345-53364A1A-F34F-4B58-8FE1-D60A700DC8D5Q83466651-79179A73-7AD3-463F-9CCB-26DAF1E12A3CQ87274530-69D9B52A-21ED-49F1-9E60-82AA7F9D27FCQ87325316-35C02A24-A589-40EC-9ABC-DDB424365157Q87649059-DC58343B-DEB4-4A08-BA18-73CCA15EF885Q88968584-B7FA21F2-AD69-40B2-9DC1-C7C946CADD86Q90667377-E3BA3A35-1286-41C0-8207-8AAF781780C6Q91509788-DC647894-6CE3-47AB-9C3D-B0A3433EEE60
P50
description
Polish internist, cardiologist
@en
Pools onderzoeker
@nl
polski lekarz, internista, intensywista, kardiolog
@pl
name
Andrzej Mysiak
@ast
Andrzej Mysiak
@ca
Andrzej Mysiak
@cs
Andrzej Mysiak
@en
Andrzej Mysiak
@es
Andrzej Mysiak
@gl
Andrzej Mysiak
@hr
Andrzej Mysiak
@hsb
Andrzej Mysiak
@it
Andrzej Mysiak
@nl
type
label
Andrzej Mysiak
@ast
Andrzej Mysiak
@ca
Andrzej Mysiak
@cs
Andrzej Mysiak
@en
Andrzej Mysiak
@es
Andrzej Mysiak
@gl
Andrzej Mysiak
@hr
Andrzej Mysiak
@hsb
Andrzej Mysiak
@it
Andrzej Mysiak
@nl
prefLabel
Andrzej Mysiak
@ast
Andrzej Mysiak
@ca
Andrzej Mysiak
@cs
Andrzej Mysiak
@en
Andrzej Mysiak
@es
Andrzej Mysiak
@gl
Andrzej Mysiak
@hr
Andrzej Mysiak
@hsb
Andrzej Mysiak
@it
Andrzej Mysiak
@nl
P214
P106
P1153
55913555200
P1412
P1559
Andrzej Mysiak
@pl
P21
P214
P27
P31
P3124
P496
0000-0002-4728-2565
P735
P7859
viaf-166938503